GLIOBLASTOMA, IDH-WILDTYPE

This study is testing whether adding an experimental drug called WP1066 to standard radiation therapy can better control a fast-growing type of brain cancer called glioblastoma. The drug is designed to block a specific pathway that helps the tumor grow and hide from the body's im…

This early-stage study is testing whether a radioactive drug called Lutetium-177-PSMA-617 is safe for people with aggressive types of brain cancer called gliomas. The treatment uses a molecule that seeks out and delivers radiation directly to tumor cells that have a specific mark…

This study is testing whether using a continuous glucose monitor (CGM) can help people with glioblastoma, a serious brain cancer, manage their blood sugar levels during treatment. High blood sugar during radiation is linked to worse survival, and steroids used in treatment often …

This study is testing a new oral medication called NEO212 for adults with specific aggressive brain tumors (like glioblastoma) or brain metastases from other cancers. The main goals are to find a safe and effective dose, see how the body processes the drug, and check if it can he…

This study is testing if adding the common diabetes drug metformin to the standard first treatment (radiation and chemotherapy) can better control a specific type of aggressive brain tumor called glioblastoma. It will include about 64 newly diagnosed patients whose tumors have a …

This study is testing if advanced imaging techniques can help doctors better understand brain scans of people with glioblastoma, a serious brain cancer. After standard radiation treatment, it can be hard to tell on a regular MRI if the tumor is actually growing or if the changes …